Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School
News from our full member the Wilmer Eye Institute – Johns Hopkins
Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.
Upcoming Chair of the Executive Board of the WAEH 2025
At the 18th Annual Meeting in China, the board of the World Association of Eye Hospitals (WAEH) proudly announced that Christine Nelson, M.D., from the Kellogg Eye Center in Ann […]
Last things to do before you leave for the 18th Annual Meeting! See the key points below! WAEH 18th Annual Meeting Tips for travelling WAEH 18th Annual Meeting China in […]
Going with the bullet train from Changsha to Shanghai? Please send us a copy of your passport if not done already! If you’d like to take the bullet train from […]
The Liberia Eye Center Liberia, in Western Africa, has an estimated age-standardised prevalence of vision loss of 17% (all causes). India has about 22%, but with a population that is […]
